Decreases in serum levels of S100 may predict response to therapy in melanoma patients treated with a polyvalent melanoma vaccine

被引:0
作者
Bar, A [1 ]
Amin, P [1 ]
Reynolds, S [1 ]
Shapiro, R [1 ]
Roses, D [1 ]
Harris, M [1 ]
Bystryn, J [1 ]
机构
[1] NYU, Sch Med, New York, NY USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
901
引用
收藏
页码:540 / 540
页数:1
相关论文
共 50 条
  • [41] Expression and clinical significance of S100 family genes in patients with melanoma
    Xiong, Ting-feng
    Pan, Fu-qiang
    Li, Dong
    MELANOMA RESEARCH, 2019, 29 (01) : 23 - 29
  • [42] S100β protein in peripheral blood may predict progressive disease during interleukin-2 based immunotherapy in patients with metastatic melanoma
    Schmidt, H
    Sorensen, BS
    Nexo, E
    von der Maase, H
    MELANOMA RESEARCH, 2004, 14 (03) : 211 - 215
  • [43] Serum cytokines in metastatic melanoma patients treated with an autologous tumor vaccine
    Schiltz, PM
    Dillman, RO
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2003, 18 (06) : 879 - 886
  • [44] Increased blood levels of human S100 in melanoma chick embryo xenografts' circulation
    Kunzi-Rapp, K
    Kaskel, P
    Steiner, R
    Peter, RU
    Krähn, G
    PIGMENT CELL RESEARCH, 2001, 14 (01): : 9 - 13
  • [45] Prognostic relevance of lactate dehydrogenase and serum S100 levels in stage IV melanoma with known BRAF mutation status
    Frauchiger, A. L.
    Mangana, J.
    Rechsteiner, M.
    Moch, H.
    Seifert, B.
    Braun, R. P.
    Dummer, R.
    Goldinger, S. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 174 (04) : 823 - 830
  • [46] Serum S100 concentrations are not useful in predicting micrometastatic disease in cutaneous malignant melanoma
    Acland, K
    Evans, AV
    Abraha, H
    Healy, CMJ
    Roblin, P
    Calonje, E
    Orchard, G
    Higgins, E
    Sherwood, R
    Russell-Jones, R
    BRITISH JOURNAL OF DERMATOLOGY, 2002, 146 (05) : 832 - 835
  • [47] Assessment of Serum S100 Protein Levels in Patients with Fibromyalgia
    Cavas, Husamettin
    Oktayoglu, Pelin
    Verim, Sabahattin
    Em, Serda
    Caglayan, Mehmet
    Bozkurt, Mehtap
    Yildiz, Ismail
    Cevik, Remzi
    Nas, Kemal
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S81 - S81
  • [48] Results of the tumormarker S100 in comparison to FDG-PET in melanoma patients
    Bogatzky, J
    Reinhold, U
    Bender, H
    Willkomm, P
    Biersack, HJ
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 269P - 269P
  • [49] Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patients
    Fabio Morandi
    Maria Valeria Corrias
    Isabella Levreri
    Paola Scaruffi
    Lizzia Raffaghello
    Barbara Carlini
    Paola Bocca
    Ignazia Prigione
    Sara Stigliani
    Loredana Amoroso
    Soldano Ferrone
    Vito Pistoia
    Cancer Immunology, Immunotherapy, 2011, 60 : 1485 - 1495
  • [50] Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patients
    Morandi, Fabio
    Corrias, Maria Valeria
    Levreri, Isabella
    Scaruffi, Paola
    Raffaghello, Lizzia
    Carlini, Barbara
    Bocca, Paola
    Prigione, Ignazia
    Stigliani, Sara
    Amoroso, Loredana
    Ferrone, Soldano
    Pistoia, Vito
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (10) : 1485 - 1495